下载本文档
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEHC-070Cat. No.: HY-112302CAS No.: 1628291-95-1分式: CHClNO分量: 475.32作靶点: TRP Channel作通路: Membrane Transporter/Ion Channel; Neuronal Signaling储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 62
2、.5 mg/mL (131.49 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 2.1038 mL 10.5192 mL 21.0385 mL5 mM 0.4208 mL 2.1038 mL 4.2077 mL10 mM 0.2104 mL 1.0519 mL 2.1038 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。体内实验 请根据您的实验动物和给药式选择适当的溶解案,配制前请先配制澄清的储备液,再依次添
3、加助溶剂(为保证实验结果的可靠性,体内实验的作液,建议您现现配,当天使;澄清的储备液可以根据储存条件,适当保存;以下溶剂前的百分 指该溶剂在您配制终溶液中的体积占):1. 请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (5.26 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (5.26 mM); Clear solution1/2 Master of Small Molecules 您边
4、的抑制剂师www.MedChemEBIOLOGICAL ACTIVITY物活性 HC-070种瞬时受体电位通道蛋 4/5 (TRPC4/TRPC5) 拮抗剂,在细胞中,对 hTRPC5 和 hTRPC4 的 IC50值分别为 9.3 nM 和 46 nM。IC50 & Target IC50: 9.3 nM (hTRPC5, cell assay), 46 nM (hTRPC4, cell assay) 1体外研究 HC-070 is an antagonist of TRPC4/TRPC5, with IC50s of 9.3 nM and 46 nM for hTRPC5 and hTRP
5、C4,respectively. HC-070 weakly inhibits TRPC3 (IC50, 1 M), and is at least 400-fold selective for humanTRPC4 and TRPC5-containing channels versus the other channels examined. HC-070 inhibits lanthanum-activated hTRPC5-, mTRPC5-, rTRPC5-mediated currents with IC50s of 0.52 nM, 0.55 nM, and 0.32 nM in
6、whole-cell manual patch clamp. Furthermore, HC-070 blocks M2R-activated human TRPC1/TRPC4 channelswith an IC50 of 1.3 nM and La3+- and M1R-activated human TRPC1/5 channels with IC50s of 1.4 nM and4.4 nM. HC-070 inhibits human TRPC5 currents activated via muscarinic type 1 (M1R) with an IC50 of 2.0nM
7、. HC-070 also suppresses hTRPC4 currents via M2R with an IC50 of 0.49 nM. HC-070 (20 nM) reducesCCK-4 evoked neuronal activity in the amygdala slices 1.体内研究 HC-070 (1 mg/kg, p.o.) affects mice with increased evoked anxiety (CCK-4), but shows no effects in theabsence of CCK-4. HC-070 (0.3, 1 or 3 mg/
8、kg, p.o.) decreases anxiety in a standard EPM (more light/highanxiety). HC-070 (1 mg/kg) reduces the increased capacity for fear memory in mice subjected to chronicsocial stress on days 1-15. In addition, HC-070 (1, 3, 10 mg/kg, p.o.) causes reduction in marble buryingbehavior. HC-070 (0.3, 1, 3, 10
9、 mg/kg, p.o.) also reduces time of immobility in a tail suspension test but doesnot impact locomotor activity in mice 1.PROTOCOLAnimal Mice 1Administration 1 The room is illuminated with fluorescent lighting on a 12-hour light/dark cycle. The light cycle is reversed, sothat the dark cycle is from 6
10、am-6 pm daily and studies are performed when animals are more active. Groupsof male C57/BL6 mice (10 weeks old) are dosed PO with 0.5% methyl cellulose or HC-070 at 0.3, 1 or 3mg/kg (n = 10). The positive control, 1.5 mg/kg diazepam, is administered IP 30 minutes prior to testing (n =10). Immediatel
11、y following dosing, mice are returned to their home cage. At 60 minutes post vehicle or HC-070 administration, and 30 minutes post diazepam administration, mice are placed onto the elevated plusmaze, one at a time, and their session recorded for 5 minutes. Videos are manually scored for number ofope
12、n arm entries by a scorer blinded to treatment. All animals that fall off the maze during the test areremoved from analysis 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Just S, et al. Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice.PLoS One. 2018 Jan 31;13(1):e0191225.McePdfHeight2/2 Master of Small Molecules 您边的抑制剂师www.MedChemECa
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2026年林长制工作知识专题测验及答案
- 2025-2026版河南初中九年级道德与法治期末试卷
- 急性肾小管-间质肾炎多学科决策模式中国专家共识(2026版)
- CN119511529A 基于一阶量设计光学系统初始结构的方法 (上海交通大学)
- 2026年计算机岗事业单位面试题库带解析
- 踝关节内部假体装置取出术多学科决策模式中国专家共识(2026版)
- 公共事业管理发展现状及策略分析
- 计算机岗事业单位面试高频题试卷带答案
- 消费者投诉管理制度
- 公共机构节能知识竞赛题库及参考答案
- 2026年水利工程安全生产A证考试题库
- 2026年经济师(中级)考试真题及答案
- 中国联通春季校园招聘笔试真题及试题及答案
- 2026年水利安全员C证备考重点题库(新版350题)
- 2026年国考公安专业知识真题及答案解析
- 2026年内蒙古自治区中考生物试卷(含答案及解析)
- 劳务派遣公司安全生产规章制度
- 公路城乡结合部交通事故处理手册 标准版
- 建筑电气设计统一技术措施-2021
- 人工气道管理专家共识(2026版)
- 电池盒相关项目建议书
评论
0/150
提交评论